Brittany Bertone
Physician Assistant · Johnston, RINPI 1588112437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $5,228 and has fallen 99.6% since, to $20 in 2025. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lundbeck LLC$628
- Teva Pharmaceuticals USA, Inc.$553
- Pfizer$551
- Genentech USA, Inc.$315
- Xeris Pharmaceuticals, Inc.$265
- plus $4K from 28 others
What the payments were for
- Food & beverage$7,09997%
- Education$1903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,195 |
| Lundbeck LLC | 31 | $628 |
| Teva Pharmaceuticals USA, Inc. | 40 | $553 |
| Pfizer | 28 | $551 |
| Genentech USA, Inc. | 15 | $315 |
| Xeris Pharmaceuticals, Inc. | 17 | $265 |
| Biogen | 18 | $257 |
| SK Life Science, Inc. | 16 | $248 |
| Novartis | 24 | $244 |
| MDD US Operations, LLC | 7 | $236 |
| Neurocrine Biosciences, Inc. | 9 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $197 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $192 |
| UCB, Inc. | 7 | $192 |
| Kyowa Kirin, Inc. | 8 | $189 |
| Jazz Pharmaceuticals Inc. | 4 | $185 |
| Orthofix Medical, Inc. | 7 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $176 |
| TG Therapeutics, Inc. | 10 | $166 |
| CSL Behring | 7 | $160 |
| Lilly USA, LLC | 8 | $152 |
| Sumitomo Pharma America, Inc. | 7 | $149 |
| Axsome Therapeutics, Inc. | 6 | $142 |
| Catalyst Pharmaceuticals, Inc. | 5 | $104 |
| Globus Medical | 5 | $76 |
| Eisai Inc. | 3 | $72 |
| EMD Serono, Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Bristol Myers Squibb | 1 | $27 |
| Cerapedics Inc. | 1 | $26 |
| AstraZeneca | 1 | $23 |
| Livanova USA, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,289 in reported general payments places this provider in the 95th percentile of 481 physician assistant providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 65 | $74,788 |
| Nurtec OdtRimegepant Sulfate | 25 | $48,777 |
| XcopriCenobamate | 46 | $44,866 |
| GocovriAmantadine Hcl | 12 | $33,659 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 27 | $19,528 |
| Emgality PenGalcanezumab-Gnlm | 21 | $14,728 |
| FycompaPerampanel | 12 | $10,932 |
| Aimovig AutoinjectorErenumab-Aooe | 15 | $10,648 |
| Lamotrigine ErLamotrigine | 27 | $7,590 |
| Lacosamide | 66 | $5,061 |
| Levetiracetam | 97 | $3,574 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 141 | $3,223 |
| Oxcarbazepine | 15 | $1,924 |
| Donepezil Hcl | 154 | $1,445 |
| Duloxetine Hcl | 58 | $1,383 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $1,195 | $74,78865 claims |
| PfizerNurtec Odt | $551 | $48,77725 claims |
| SK Life Science, Inc.Xcopri | $248 | $44,86646 claims |
| MDD US Operations, LLCGocovri | $236 | $33,65912 claims |
| Eisai Inc.Fycompa | $72 | $10,93212 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $29 | $84013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 481 physician assistant providers in Rhode Island.
Other physician assistant in Johnston
- Laura HilliardJohnston$6K
- Gillian MelikianJohnston$4K
- Jennifer GeremiaCranston$370K
- Stephanie MarlinLincoln$37K
- Thomas BalesProvidence$28K
- Alfred LiddleLincoln$23K
- Maeve TobinPawtucket$21K
- Taylor DrydenLincoln$15K
- Raquel BertolottiEast Greenwich$13K
- Kathryn WisnewskiPawtucket$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.